DOW JONES23,134.57+480.71 2.12%
S&P 5002,712.87+53.46 2.01%
NASDAQ8,050.03+162.77 2.06%

JP Morgan Maintains Overweight on Takeda Pharmaceutical, Lowers Price Target to $30

JP Morgan maintains Takeda Pharmaceutical (NYSE:TAK) with a Overweight and lowers the price target from $31 to $30.

Benzinga · 03/11/2020 15:12

JP Morgan maintains Takeda Pharmaceutical (NYSE:TAK) with a Overweight and lowers the price target from $31 to $30.